Terlipressin Administration in Patients Undergoing Major Liver Resection: a Prospective Randomized Blinded Trial

NCT01921985 Phase 2 TERMINATED

This study investigates if the administration of terlipressin reduces complications after major liver surgery.

Details

Lead sponsor	Insel Gruppe AG, University Hospital Bern
Phase	Phase 2
Status	TERMINATED
Enrolment	150
Start date	2013-11
Completion	2018-03

Conditions

• Liver Resection
• Liver Failure

Interventions

• Terlipressin
• Placebo

Primary outcomes

• Number of patients with incident of a composite end point — one month

Countries

Switzerland